Intestinal GLP-1 and satiation: from man to rodents and back (Q38575560)

4 September 2017

title

Intestinal GLP-1 and satiation: from man to rodents and back (English)

1 reference

4 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315842%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

C Beglinger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315842%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

W Langhans

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315842%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

language of work or name

English

0 references

publication date

28 August 2015

1 reference

International Journal of Obesity

4 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315842%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315842%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315842%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

198-205

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26315842%20AND%20SRC:MED&resulttype=core&format=json

All bariatric surgeries are not created equal: insights from mechanistic comparisons

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Hormone changes affecting energy homeostasis after metabolic surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Endocrine controls of eating: CCK, leptin, and ghrelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Gastrointestinal satiety signals in humans--physiologic roles for GLP-1 and PYY?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

The ileal brake--inhibition of jejunal motility after ileal fat perfusion in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

The Physiology of Glucagon-like Peptide 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Gastric and intestinal satiation in obese and normal weight healthy people

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Role of fat hydrolysis in regulating glucagon-like Peptide-1 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Effects of intraduodenal fatty acids on appetite, antropyloroduodenal motility, and plasma CCK and GLP-1 in humans vary with their chain length

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Effects of intraduodenal glutamine on incretin hormone and insulin release, the glycemic response to an intraduodenal glucose infusion, and antropyloroduodenal motility in health and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Glucagon-like peptide-1 release and satiety after a nutrient challenge in normal-weight and obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Pooled-data analysis identifies pyloric pressures and plasma cholecystokinin concentrations as major determinants of acute energy intake in healthy, lean men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Effects of carbohydrate sugars and artificial sweeteners on appetite and the secretion of gastrointestinal satiety peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Changes in gut hormone and glucose concentrations in relation to hunger and fullness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Comparison of postprandial profiles of ghrelin, active GLP-1, and total PYY to meals varying in fat and carbohydrate and their association with hunger and the phases of satiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Fasting and postprandial concentrations of GLP-1 in intestinal lymph and portal plasma: evidence for selective release of GLP-1 in the lymph system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Stimulation of incretin secretion by dietary lipid: is it dose dependent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

21 January 2018

GPR119 as a fat sensor

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Meal-contingent intestinal lymph sampling from awake, unrestrained rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Hunger selectively modulates corticolimbic activation to food stimuli in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Brain activity in hunger and satiety: an exploratory visually stimulated FMRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Postprandial glucagon-like peptide-1 (GLP-1) response is positively associated with changes in neuronal activity of brain areas implicated in satiety and food intake regulation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Correlations of macronutrient-induced functional magnetic resonance imaging signal changes in human brain and gut hormone responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

The gut hormones PYY 3-36 and GLP-1 7-36 amide reduce food intake and modulate brain activity in appetite centers in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Neuroendocrine function and response to stress in mice with complete disruption of glucagon-like peptide-1 receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Targeted gene disruption in endocrine research--the case of glucagon-like peptide-1 and neuroendocrine function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Vagal afferents mediate early satiation and prevent flavour avoidance learning in response to intraperitoneally infused exendin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Glucagon-like peptide-1: a potent regulator of food intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Evaluation of interactions between CCK and GLP-1 in their effects on appetite, energy intake, and antropyloroduodenal motility in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Incretin hormones and the satiation signal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Integrated upper gastrointestinal response to food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Oral administration of glucagon-like peptide 1 or peptide YY 3-36 affects food intake in healthy male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

21 January 2018

Understanding synergy

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Interaction between GLP-1 and CCK-33 in inhibiting food intake and appetite in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Microanatomy of the intestinal lymphatic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Lymphatics in intestinal transport of nutrients and gastrointestinal hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Effect of glucagon-like peptide-1 receptor antagonism on appetite and food intake in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Initial evidence that GLP-1 receptor blockade fails to suppress postprandial satiety or promote food intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Effect of peptide YY3-36 on food intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Gut hormone PYY(3-36) physiologically inhibits food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

The effects of GLP-1 infusion in the hepatic portal region on food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

GLP-1 antagonism with exendin (9-39) fails to increase spontaneous meal size in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

A novel human-based receptor antagonist of sustained action reveals body weight control by endogenous GLP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Physiology of GLP-1--lessons from glucoincretin receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Secretion of the Incretin Hormones Glucagon-Like Peptide-1 and Gastric Inhibitory Polypeptide Correlates with Insulin Secretion in Normal Man Throughout the Day

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Effects of PYY3–36 and GLP-1 on energy intake, energy expenditure, and appetite in overweight men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

The temporal response of the brain after eating revealed by functional MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men

21 January 2018

1 reference

12 December 2020

Effects of a preload on reduction of food intake by GLP-1 in healthy subjects

1 reference

12 December 2020

Effects of intraduodenal infusion of L-tryptophan on ad libitum eating, antropyloroduodenal motility, glycemia, insulinemia, and gut peptide secretion in healthy men

1 reference

12 December 2020

Appetite hormones and energy intake in obese men after consumption of fructose, glucose and whey protein beverages

1 reference

12 December 2020

Load-dependent effects of duodenal glucose on glycemia, gastrointestinal hormones, antropyloroduodenal motility, and energy intake in healthy men

1 reference

12 December 2020

Circulating glucagon-like peptide-1 (GLP-1) inhibits eating in male rats by acting in the hindbrain and without inducing avoidance

1 reference

12 December 2020

Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2.

1 reference

12 December 2020

Obesity: preventing and managing the global epidemic. Report of a WHO consultation

1 reference

12 December 2020

Oral triacylglycerols regulate plasma glucagon-like peptide-1(7-36) and insulin levels in normal and especially in obese rats

1 reference

12 December 2020

Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine.

1 reference

12 December 2020

The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction

1 reference

12 December 2020

No effect of glucagon-like peptide-1 on short-term satiety and energy intake in man

1 reference

12 December 2020

Intraduodenal protein modulates antropyloroduodenal motility, hormone release, glycemia, appetite, and energy intake in lean men

1 reference

12 December 2020

Effect of infusion of nutrient solutions into the ileum on gastrointestinal transit and plasma levels of neurotensin and enteroglucagon

1 reference

12 December 2020

Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats

1 reference

12 December 2020

Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39

1 reference

12 December 2020

The role of the stomach in the control of appetite and the secretion of satiation peptides

1 reference

12 December 2020

Gut peptides and postprandial satiety

1 reference

12 December 2020

Cholecystokinin decreases food intake in rats.

1 reference

12 December 2020

Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men.

1 reference

12 December 2020

Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide I

1 reference

12 December 2020

Comparison of the postprandial release of peptide YY and proglucagon-derived peptides in the rat

1 reference

12 December 2020

Effect of low glycogen on carbohydrate and energy metabolism in human muscle during exercise

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2015.172

7 January 2021